These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32422019)

  • 21. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance.
    Cusi K; DeFronzo R
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3077-84. PubMed ID: 10999789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus.
    Boden G; Chen X; Stein TP
    Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E23-30. PubMed ID: 11120655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
    Magnussen LV; Glintborg D; Hermann P; Hougaard DM; Højlund K; Andersen M
    Diabetes Obes Metab; 2016 Oct; 18(10):980-9. PubMed ID: 27265844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin K1 inversely correlates with glycemia and insulin resistance in patients with type 2 diabetes (T2D) and positively regulates SIRT1/AMPK pathway of glucose metabolism in liver of T2D mice and hepatocytes cultured in high glucose.
    Dihingia A; Ozah D; Ghosh S; Sarkar A; Baruah PK; Kalita J; Sil PC; Manna P
    J Nutr Biochem; 2018 Feb; 52():103-114. PubMed ID: 29175667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance training enhances insulin suppression of endogenous glucose production in elderly women.
    Honka MJ; Bucci M; Andersson J; Huovinen V; Guzzardi MA; Sandboge S; Savisto N; Salonen MK; Badeau RM; Parkkola R; Kullberg J; Iozzo P; Eriksson JG; Nuutila P
    J Appl Physiol (1985); 2016 Mar; 120(6):633-9. PubMed ID: 26744506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amylin effect in extrapancreatic tissues participating in glucose homeostasis, in normal, insulin-resistant and type 2 diabetic state.
    Moreno P; Acitores A; Gutiérrez-Rojas I; Nuche-Berenguer B; El Assar M; Rodriguez-Mañas L; Gomis R; Valverde I; Visa M; Malaisse WJ; Novials A; González N; Villanueva-Peñacarrillo ML
    Peptides; 2011 Oct; 32(10):2077-85. PubMed ID: 21939703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.
    Asghar Z; Yau D; Chan F; Leroith D; Chan CB; Wheeler MB
    Diabetologia; 2006 Jan; 49(1):90-9. PubMed ID: 16362284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.
    Bajaj M; Suraamornkul S; Hardies LJ; Pratipanawatr T; DeFronzo RA
    Int J Obes Relat Metab Disord; 2004 Jun; 28(6):783-9. PubMed ID: 15024400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of a mild decrease in fasting plasma glucose on β-cell function in healthy subjects and patients with type 2 diabetes.
    Seghieri M; Rebelos E; Astiarraga BD; Baldi S; Mari A; Ferrannini E
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E919-24. PubMed ID: 27072495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver.
    Halter JB; Ward WK; Porte D; Best JD; Pfeifer MA
    Am J Med; 1985 Aug; 79(2B):6-12. PubMed ID: 2863979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes.
    Ferrannini E; Baldi S; Frascerra S; Astiarraga B; Heise T; Bizzotto R; Mari A; Pieber TR; Muscelli E
    Diabetes; 2016 May; 65(5):1190-5. PubMed ID: 26861783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of insulin secretion and resistance in type 2 diabetes of adolescents.
    Druet C; Tubiana-Rufi N; Chevenne D; Rigal O; Polak M; Levy-Marchal C
    J Clin Endocrinol Metab; 2006 Feb; 91(2):401-4. PubMed ID: 16291705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes-Associated Variation in TCF7L2 Is Not Associated With Hepatic or Extrahepatic Insulin Resistance.
    Varghese RT; Viegas I; Barosa C; Marques C; Shah M; Rizza RA; Jones JG; Vella A
    Diabetes; 2016 Apr; 65(4):887-92. PubMed ID: 26822092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of myokines in the development of skeletal muscle insulin resistance and related metabolic defects in type 2 diabetes.
    Garneau L; Aguer C
    Diabetes Metab; 2019 Dec; 45(6):505-516. PubMed ID: 30844447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose intolerance in monosodium glutamate obesity is linked to hyperglucagonemia and insulin resistance in α cells.
    Araujo TR; da Silva JA; Vettorazzi JF; Freitas IN; Lubaczeuski C; Magalhães EA; Silva JN; Ribeiro ES; Boschero AC; Carneiro EM; Bonfleur ML; Ribeiro RA
    J Cell Physiol; 2019 May; 234(5):7019-7031. PubMed ID: 30317580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Mouse Model of Beta-Cell Dysfunction as Seen in Human Type 2 Diabetes.
    Parilla JH; Willard JR; Barrow BM; Zraika S
    J Diabetes Res; 2018; 2018():6106051. PubMed ID: 29854823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gadofullerene Nanoparticles Reverse Dysfunctions of Pancreas and Improve Hepatic Insulin Resistance for Type 2 Diabetes Mellitus Treatment.
    Li X; Zhen M; Zhou C; Deng R; Yu T; Wu Y; Shu C; Wang C; Bai C
    ACS Nano; 2019 Aug; 13(8):8597-8608. PubMed ID: 31314991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.